Innovations and paradigm shifts in atrial fibrillation ablation. (9th April 2021)

• Record Type: Journal Article
• Authors: Mulder, Bart A; Luermans, Justin G L M; Hindricks, Gerhard; Blaauw, Yuri
• Is Part Of: Europace. Volume 23:Supplement 2(2021)
• Page Start: ii23
• Page End: ii27
• Publication Date: 2021-04-09
• Subjects: Atrial fibrillation -- Pulmonary vein isolation -- Technology -- Innovations -- Review; Arrhythmia -- Treatment -- Periodicals; Cardiac pacing -- Periodicals; Catheter ablation -- Periodicals; Heart -- Physiology -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1093/europace/euaa418
• Languages: English
• ISSNs: 1099-5129

Abstract

Abstract: Treatment of symptomatic atrial fibrillation has seen important changes in the past decades. Advancements have especially been made in the field of non-pharmacological treatment of this disease. Patients in whom a rhythm control strategy is chosen the place of catheter ablation has become more frontline therapy in the past years. The procedure itself has also seen changes in technologies that can be used, either using point-by-point radiofrequency or one of the single-shot techniques. One of the major limitations that remain is that re-do procedures are often necessary due to incomplete pulmonary vein isolation and/or atrial fibrillation being initiated by other mechanisms than pulmonary vein triggers. Therefore, there is further need for developing ablation tools that reproducibly isolate the pulmonary vein transmurally. Furthermore, addressing the underlying conditions before and after catheter ablation has been shown to be of great importance. In this review, we will give an overview of the evolution of catheter ablation, highlight the latest technologies and their future endeavours, and lifestyle modifications are being discussed as part of the catheter ablation strategy.